CS215108B2 - Method of making the interferrone - Google Patents

Method of making the interferrone Download PDF

Info

Publication number
CS215108B2
CS215108B2 CS784645A CS464578A CS215108B2 CS 215108 B2 CS215108 B2 CS 215108B2 CS 784645 A CS784645 A CS 784645A CS 464578 A CS464578 A CS 464578A CS 215108 B2 CS215108 B2 CS 215108B2
Authority
CS
Czechoslovakia
Prior art keywords
cells
interferon
concentration
acid
sodium
Prior art date
Application number
CS784645A
Other languages
Czech (cs)
English (en)
Inventor
Denis Johnston
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of CS215108B2 publication Critical patent/CS215108B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
CS784645A 1977-07-15 1978-07-11 Method of making the interferrone CS215108B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2987177 1977-07-15

Publications (1)

Publication Number Publication Date
CS215108B2 true CS215108B2 (en) 1982-07-30

Family

ID=10298554

Family Applications (1)

Application Number Title Priority Date Filing Date
CS784645A CS215108B2 (en) 1977-07-15 1978-07-11 Method of making the interferrone

Country Status (15)

Country Link
US (1) US4216203A (fi)
EP (1) EP0000520B1 (fi)
JP (1) JPS5420119A (fi)
AT (1) AT362334B (fi)
AU (1) AU524099B2 (fi)
CA (1) CA1115209A (fi)
CS (1) CS215108B2 (fi)
DE (1) DE2860559D1 (fi)
DK (1) DK147625C (fi)
ES (1) ES471721A1 (fi)
FI (1) FI60971C (fi)
HU (1) HU179655B (fi)
IL (1) IL55143A0 (fi)
IT (1) IT1107573B (fi)
PL (1) PL110704B1 (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2961658D1 (en) * 1978-05-17 1982-02-18 Thomae Gmbh Dr K Process for preparing human interferon
JPS55122717A (en) * 1979-03-15 1980-09-20 Asai Gerumaniumu Kenkyusho:Kk Interferon inducer
DE2946275A1 (de) * 1979-11-16 1981-05-27 Dr. Karl Thomae Gmbh, 7950 Biberach Verbessertes verfahren zur herstellung von humaninterferon aus lymphoblastoiden zellen
JPS56135420A (en) * 1980-03-26 1981-10-22 Fumiaki Taguchi Suppressive substance of virus and its preparation
ES8302096A1 (es) 1980-04-03 1982-12-16 Biogen Nv Un metodo de producir un polipeptido que muestra una actividad immunologica obiologica de interferon de fibroblasto hu- mano.
US4460574A (en) * 1980-06-16 1984-07-17 Yabrov Alexander A Prophylaxis or treatment of interferon-sensitive diseases
JPS5754586A (en) * 1980-09-18 1982-04-01 Ajinomoto Co Inc Cell strain producing human interferon prolongably, its preparation, and preparation of human interferon using it
FR2502009A1 (fr) * 1981-03-23 1982-09-24 Centre Nat Rech Scient Perfectionnements aux procedes de fabrication d'interferon
EP0062085B1 (de) * 1981-04-07 1985-08-14 Dr. Karl Thomae GmbH Verbessertes Verfahren zur Herstellung von Humaninterferon aus lymphoblastoiden Zellen
HU184972B (en) * 1981-12-01 1984-11-28 Egyt Gyogyszervegyeszeti Gyar Process for preparing human gamma interferone
JPH0636751B2 (ja) * 1982-06-21 1994-05-18 ザ・ウエルカム・フアウンデ−シヨン・リミテツド インタ−フエロンの改良製法
US4745053A (en) * 1983-07-08 1988-05-17 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyojo Process for producing human interferon and method for assaying the interferon productivity of blood
US6774283B1 (en) 1985-07-29 2004-08-10 Calgene Llc Molecular farming
US4956282A (en) * 1985-07-29 1990-09-11 Calgene, Inc. Mammalian peptide expression in plant cells
DE3930140A1 (de) * 1989-09-09 1991-03-21 Bayer Ag Verfahren zur herstellung von biologischen materialien in zellkulturen und vorrichtungen
US5378612A (en) * 1990-05-11 1995-01-03 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Culture medium for production of recombinant protein
JPH0775593A (ja) * 1993-09-08 1995-03-20 Suntory Ltd 蛋白質の製造方法
US6214535B1 (en) * 1995-08-30 2001-04-10 Toray Industries, Inc. Method for testing cardiac myocarditis or cardiomyopathy
US6833271B2 (en) * 1996-12-04 2004-12-21 Medi-Cult A/S Serum-free cell culture media
SE513313C2 (sv) 1998-12-29 2000-08-21 Bionative Ab Modifierad interferonproduktion
US7294481B1 (en) * 1999-01-05 2007-11-13 Immunex Corporation Method for producing recombinant proteins
GB0208041D0 (en) * 2002-04-08 2002-05-22 Lonza Biologics Plc Method of culturing animal cells
JP7015917B2 (ja) 2018-05-31 2022-02-03 東芝キヤリア株式会社 タッチパネルを用いた設備管理装置および管理画面生成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2282910A2 (fr) 1974-08-26 1976-03-26 Anvar Procede de fabrication a l'echelle industrielle de preparations d'interferon de titre eleve
GB1464939A (en) * 1974-01-11 1977-02-16 Anvar Process for the production of interferon

Also Published As

Publication number Publication date
IL55143A0 (en) 1978-09-29
CA1115209A (en) 1981-12-29
DK316978A (da) 1979-01-16
AU524099B2 (en) 1982-09-02
DK147625B (da) 1984-10-22
IT7850322A0 (it) 1978-07-14
JPS5646797B2 (fi) 1981-11-05
PL208407A1 (pl) 1979-03-12
DE2860559D1 (en) 1981-04-16
FI60971B (fi) 1982-01-29
ATA510378A (de) 1980-10-15
US4216203A (en) 1980-08-05
EP0000520B1 (en) 1981-03-25
JPS5420119A (en) 1979-02-15
FI782249A (fi) 1979-01-16
IT1107573B (it) 1985-11-25
PL110704B1 (en) 1980-07-31
AT362334B (de) 1981-05-11
EP0000520A1 (en) 1979-02-07
HU179655B (en) 1982-11-29
DK147625C (da) 1985-04-29
ES471721A1 (es) 1979-02-01
FI60971C (fi) 1982-05-10
AU3804978A (en) 1980-01-17

Similar Documents

Publication Publication Date Title
CS215108B2 (en) Method of making the interferrone
US4820514A (en) Low dosage of interferon to enhance vaccine efficiency
US4276282A (en) Interferon and preparations containing interferon
US5518899A (en) Preparation of human myelomonocyte interferon-gamma
AU6642390A (en) Methods and compositions for promoting immunopotentiation
Furth Recent experimental studies on leukemia
Wittmann et al. Cell-mediated immunity in Aujeszky disease virus infected pigs: I. Lymphocyte stimulation
CA1340698C (en) Preparation and uses of interferon-gamma
CS251766B2 (en) Method of interferon production
EP0538330B1 (en) Beta-alethine use in cell culture and therapy
Deodhar Enhancement of metastases by L-asparaginase in a mouse tumour system
US4480032A (en) Natural mixture of Type I and Type II interferons
US4452893A (en) Cell growth medium supplement
Sugama et al. 2‐Mercaptoethanol acts at the restricted stage of interleukin‐2 dependent lymphocyte proliferation
SU1830080A3 (ru) Бессыворотомная питательная среда для культуры ткани
US6245561B1 (en) β-alethine use in cell culture and therapy
CHUDZIO et al. SHORT COMMUNICATION Platelet-Derived Growth Factor (PDGF) Inhibits Priming in Synchronous Mouse or Human Fibroblasts Producing Interferon
US4994556A (en) Novel lymphokine and its production and uses
CA2087883C (en) Beta-alethine use in cell culture and therapy
SU1495374A1 (ru) Штамм культивируемых клеток животных MUS мUSсULUS - продуцент ростстимулирующих факторов гибридом
JPS6293300A (ja) インタ−フエロン組成物
WO1988000236A1 (en) Methods and materials for vanadium immunomodulation
Negroni et al. Antigenic heterogeneity in cell populations of cloned polyoma, virus-induced tumour lines
EP0093375A1 (de) Kulturmedium und Verfahren zur Virusvermehrung in Suspensionskultur
Cowdery, Jr et al. T cell mediated polyclonal B cell activation induced by cell-bound fetal calf serum